-
Akebia Therapeutics' (AKBA) "Buy" Rating Reaffirmed at HC Wainwright
ソース: Buzz FX / 15 3 2025 08:54:17 America/Chicago
Akebia Therapeutics' (AKBA) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Akebia Therapeutics ( NASDAQ:AKBA - Get Free Report ) 's stock had its "buy" rating restate
Read more...